Groowe Groowe / Newsroom / BMY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BMY News

Bristol-Myers Squibb Co.

Discovery Could Make Immune Checkpoint Inhibitors Safer

prnewswire.com
BMY MRK

Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading Companies - Gilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More

globenewswire.com
GILD NVS BMY ORGN

Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D

businesswire.com
NVS BMY AMGN

Cancer & Antibody Conjugates Patent Landscape Analysis 2025: 3761 Patent Families - IP Trends, Including Time Evolution of Published Patents and Countries of Patent Filings

globenewswire.com
PFE BMY ABBV AZN GILD

Impact Podcast with John Shegerian Announces All-Star Roster for New Season

businesswire.com
CROX AMZN MSFT V ZM CBRE HPQ IBM UBER PEP AVD NU TD UPS CRM FTI AMGN HON KHC MAR MORN FDX HTHT LVS SCL SNA WMT XOM GE JNJ KO PG TGT DIS MCD SBUX BA CAT DD EMR LMT MMM NEE RTX UNH XRAY ZTS AMAT ADSK BIIB BMY CDNS CHKP CTAS CTSH DLTR EA EXPE FAST FIS GILD GOOG HAS HPE INTC INTU ISRG JD LRCX LIN LULU LYFT MDLZ MNST MRNA MU NFLX NVDA ORCL PAYX PDD PFE PLTR PPC QCOM REGN ROST SIRI SNPS SWKS SYK TCOM TEAM TER TFX TXN ULTA VRSK VRTX WDC WEC WST WYNN XEL ZBRA SAN

Cancer Stress Protein Helps Tumors Hide From Immunity

prnewswire.com
PFE BMY KYMR AGIO BDTX PRTA

CAR T - Cell Therapy Competitive Landscape Research Report 2026: Comprehensive Insights About 250+ Companies and 500+ Drugs - Key Opportunities Lie in Targeting Hematologic Malignancies

globenewswire.com
BMY AUTL SANA

Monoclonal Antibodies Competitive Landscape Report 2026: Comprehensive Insights About 180+ Companies and 230+ Drugs by Company, Product, Stage of Development, Route of Administration, Molecule Type

globenewswire.com
BMY GSK NVS NVO

Molecular Glues Competitive Landscape Research Report 2026: Comprehensive Insights About 80+ Companies and 90+ Drugs

globenewswire.com
BMY RVMD NRIX

Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development

businesswire.com
AZN BMY